NXGL
NEXGEL, Inc.
NASDAQ · USHealthcareMedical - Instruments & Supplies
$0.45-5.49%
Price as of Jul 20, 2026
NXGL profitability
NEXGEL, Inc. profitability
Margins, returns on capital and operating-efficiency metrics from the latest trailing period.
Margins
- Gross margin
- 38.9%
- EBITDA margin
- -19.8%
- EBIT margin
- -31.4%
- Net margin
- -28.5%
- Free cash flow margin
- -12.6%
Returns
- Return on equity
- -80.5%
- Return on assets
- -27.7%
- Return on invested capital
- -42.7%
- Asset turnover
- 1.02x
Cash efficiency
- Cash from operations
- -$1.4M
- Cash per share
- $0.02
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.